Drugs of Muscle Wasting and Their Therapeutic Targets
Authors:
- 3 November 2018
- book chapter
- Published by Springer Nature
- Vol. 1088, 463-481
Abstract
Muscle wasting and weakness such as cachexia, atrophy, and sarcopenia are characterized by marked decreases in the protein content, myonuclear number, muscle fiber size, and muscle strength. This chapter focuses on the recent advances of pharmacological approach for attenuating muscle wasting. A myostatin-inhibiting approach is very intriguing to prevent sarcopenia but not muscular dystrophy in humans. Supplementation with ghrelin is also an important candidate to combat sarcopenia as well as cachexia. Treatment with soy isoflavone, trichostatin A (TSA), and cyclooxygenase 2 (Cox2) inhibitors seems to be effective modulators attenuating muscle wasting, although further systematic research is needed on this treatment in particular concerning side effects.Keywords
This publication has 109 references indexed in Scilit:
- Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green teaHistochemistry and Cell Biology, 2012
- Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle massJournal of Cachexia, Sarcopenia and Muscle, 2012
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trialJournal of Cachexia, Sarcopenia and Muscle, 2011
- The ghrelin axis in disease: Potential therapeutic indicationsMolecular and Cellular Endocrinology, 2011
- mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle MassCell Metabolism, 2011
- Ghrelin for cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2010
- Skeletal muscle autophagy and apoptosis during aging: Effects of calorie restriction and life-long exerciseExperimental Gerontology, 2010
- Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx miceClinical Nutrition, 2009
- Sarcopenia: etiology, clinical consequences, intervention, and assessmentOsteoporosis International, 2009
- Relation of Angiotensin-Converting Enzyme Inhibitor Treatment to Insulin-Like Growth Factor-1 Serum Levels in Subjects >65 Years of Age (the InCHIANTI Study)The American Journal of Cardiology, 2006